CMIC CMO USA Corporation is a member of the CMIC Group, a company with facilities in 8 countries and over 5900 employees worldwide. Our FDA-registered facility is located in Central New Jersey. We specialize in the formulation development and GMP commercial manufacturing of NDA and ANDA solid dosage products with expertise in sustained and controlled release products. We will guide you towards regulatory approval and commercial launch while also helping you reduce your development cycles and capital costs.
Tim Wright, Editor||March 9, 2016 Contract Pharma asked a roundtable of business leaders from Symbiosis, Grifols, Althea, LSNE and Baxter to discuss key trends in the parenteral dosage development and manufacturing market
Sean Moloughney, Nutraceuticals World||March 9, 2016 Ensuring nutraceuticals are produced safely and according to strict quality requirements is paramount in the current climate of regulatory scrutiny.